MedTrace Logo

Efficacy Study of Iferanserin to Treat Hemorrhoids

NCT01483833 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 121

Last updated 2013-08-21

No results posted yet for this study

Summary

To evaluate the safety and efficacy of topical 0.5% S-MPEC cream vs. placebo cream (applied twice daily for 14 days) in the treatment of Grade I - III hemorrhoids.

Conditions

Interventions

DRUG

Iferanserin

Iferanserin 0.5% ointment applied intra-anally twice daily for 14 days

DRUG

Placebo

Placebo ointment applied intra-anally twice daily for 14 days

Sponsors & Collaborators

  • Ventrus Biosciences, Inc

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-09-30
Primary Completion
2002-08-31
Completion
2002-08-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01483833 on ClinicalTrials.gov